The DOI matches its Crossref record.
Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant.
Abstract
The aim of this study was to identify early clinical and pathologic variates that independently predict diminished renal allograft function at 24 mo posttransplant. A clinical pathologic data base was prospectively derived from 71 patients in whom protocol renal biopsies were performed at 1, 2, 3, 6, and 12 mo posttransplant. The major end point was the 24-mo serum creatinine. Variates correlating independently (r2 = 0.67) with the 24-mo serum creatinine were the chronic biopsy scores (months 3 and 6), late rejections (months 4 to 6), cyclosporin A (CsA) levels (months 1 to 2), and delayed graft function. The adjusted odds ratio (OR) and 95% confidence interval (CI) for having a serum creatinine > or = 130 mumol/L at 24 mo increased for every year the donor age increased (OR = 1.07; 95% CI, 1.02 to 1.13; range, 9 to 55) or for each late rejection episode (OR = 5.9; 95% CI, 1.7 to 20.1), whereas a mean CsA level > 300 micrograms/L from months 1 to 3 was protective (OR = 0.07; 95% CI, 0.01 to 0.43). Variates correlating independently (r2 = 0.53) with the change in serum creatinine from 6 to 24 mo (delta Cr6-24) were the chronic biopsy scores at months 3 and 6. The adjusted OR of the delta Cr6-24 rising > or = +20 mumol/L increased for every year the donor age increased (OR = 1.09; 95% CI, 1.02 to 1.16; range 9 to 56) or when the 6-mo chronic biopsy score was > or = 2 (OR = 6.6; 95% CI, 1.2 to 36.4). An estimate of the relative risk for diminished renal function at 2 yr can be assigned within 6 mo of transplant based on chronic pathology, late acute rejections, CsA levels, and donor age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
Self-citationThe Natural History of Chronic Allograft Nephropathy
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Allen, R. D. M., & Chapman, J. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020009 · Cited by 1,949
Yarlagadda, S. G., Coca, S. G., Formica, R. N., Poggio, E. D., & Parikh, C. R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn667 · Cited by 767
Beneficial effects of treatment of early subclinical rejection: a randomized study.
Rush, D., Nickerson, P., Gough, J., McKenna, R., Grimm, P., Cheang, M., Trpkov, K., Solez, K., & Jeffery, J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9112129 · Cited by 472
Self-citationRethinking Chronic Allograft Nephropathy: The Concept of Accelerated Senescence
HALLORAN, P. F., MELK, A., & BARTH, C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101167 · Cited by 452
Marked variation in the definition and diagnosis of delayed graft function: a systematic review
Yarlagadda, S. G., Coca, S. G., Garg, A. X., Doshi, M., Poggio, E., Marcus, R. J., & Parikh, C. R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn158 · Cited by 394
Chronic Allograft Nephropathy: Current Concepts and Future Directions
Nankivell, B. J., & Chapman, J. R. (2006) · Transplantation · doi:10.1097/01.tp.0000190423.82154.01 · Cited by 338
Telomere Shortening in Kidneys with Age
MELK, A., RAMASSAR, V., HELMS, L. M. H., MOORE, R., RAYNER, D., SOLEZ, K., & HALLORAN, P. F. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113444 · Cited by 189
Metadata
- Authors
- Nickerson, P., Jeffery, J., Gough, J., McKenna, R., Grimm, P., Cheang, M., & Rush, D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1998-03
- Volume
- 9
- Issue
- 3
- Pages
- 482-487
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W1935012135
- Cited by
- 163
- References
- 0
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.